Orthopedic Devices - LATAM

LATAM

Highlights

The projected revenue in the Orthopedic Devices market market in LATAM is expected to reach US$3.86bn by 2024.
Looking ahead, the market is anticipated to demonstrate a steady annual growth rate (CAGR 2024-2029) of 4.53%, resulting in a market volume of US$4.82bn by 2029.
In comparison to other countries around Worldwide, the United States is expected to generate the highest revenue in this market, reaching US$16.02bn in 2024.
In LATAM, the demand for orthopedic devices is rising due to an aging population and an increase in sports-related injuries.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

Orthopedic Devices market in LATAM is experiencing significant growth due to several factors. Customer preferences for advanced medical technology, increasing prevalence of orthopedic conditions, and rising healthcare expenditure are driving the demand for orthopedic devices in the region. Customer preferences in LATAM are shifting towards advanced medical technology, including orthopedic devices. Patients are increasingly seeking minimally invasive surgical procedures and technologically advanced implants that offer better outcomes and faster recovery. This preference is driving the demand for orthopedic devices with innovative features and improved functionality. The market is also benefiting from the increasing prevalence of orthopedic conditions in LATAM. The region has a large aging population, which is prone to orthopedic conditions such as osteoarthritis and fractures. Additionally, the sedentary lifestyle and increasing obesity rates in the region are contributing to a higher incidence of orthopedic conditions. As a result, there is a growing need for orthopedic devices such as joint replacements, spinal implants, and trauma fixation devices. Rising healthcare expenditure in LATAM is another key factor driving the growth of the orthopedic devices market. Governments in the region are increasing their healthcare budgets to improve access to healthcare services and enhance healthcare infrastructure. This increased investment in healthcare is enabling patients to afford orthopedic procedures and devices, leading to higher demand. In addition to these global trends, there are some local special circumstances that are influencing the orthopedic devices market in specific countries in LATAM. For example, Brazil has a large private healthcare sector, which is driving the demand for premium orthopedic devices. Mexico, on the other hand, has a high prevalence of diabetes, which increases the risk of orthopedic complications and drives the demand for orthopedic devices. Underlying macroeconomic factors such as economic growth and healthcare infrastructure development also play a significant role in the growth of the orthopedic devices market in LATAM. As the economies in the region continue to grow, there is an increase in disposable income and healthcare spending. This, coupled with investments in healthcare infrastructure, creates a favorable environment for the growth of the orthopedic devices market. In conclusion, the Orthopedic Devices market in LATAM is experiencing significant growth due to customer preferences for advanced medical technology, increasing prevalence of orthopedic conditions, rising healthcare expenditure, local special circumstances, and underlying macroeconomic factors. This growth is expected to continue as the region's healthcare sector continues to develop and patients seek better treatment options for orthopedic conditions.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.